MELE, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 4.465
AS - Asia 1.686
EU - Europa 1.541
SA - Sud America 445
Continente sconosciuto - Info sul continente non disponibili 229
AF - Africa 83
OC - Oceania 5
Totale 8.454
Nazione #
US - Stati Uniti d'America 4.371
SG - Singapore 629
IT - Italia 600
CN - Cina 422
BR - Brasile 350
HK - Hong Kong 180
SE - Svezia 179
RU - Federazione Russa 174
VN - Vietnam 125
DE - Germania 120
FR - Francia 103
FI - Finlandia 85
GB - Regno Unito 84
BD - Bangladesh 73
IN - India 58
UA - Ucraina 56
CA - Canada 50
ID - Indonesia 34
IQ - Iraq 33
MX - Messico 26
AR - Argentina 25
CI - Costa d'Avorio 24
ES - Italia 21
NL - Olanda 21
ZA - Sudafrica 21
PL - Polonia 20
BE - Belgio 19
EC - Ecuador 18
CO - Colombia 17
JP - Giappone 17
PK - Pakistan 15
TR - Turchia 14
CZ - Repubblica Ceca 11
UZ - Uzbekistan 10
CL - Cile 9
MY - Malesia 9
RS - Serbia 9
VE - Venezuela 9
JO - Giordania 8
AT - Austria 7
KZ - Kazakistan 7
PH - Filippine 7
SA - Arabia Saudita 7
UY - Uruguay 7
IE - Irlanda 6
LT - Lituania 6
MA - Marocco 6
AU - Australia 5
CR - Costa Rica 5
EG - Egitto 5
IL - Israele 5
KE - Kenya 5
OM - Oman 5
PE - Perù 5
SN - Senegal 5
TH - Thailandia 5
TN - Tunisia 5
DZ - Algeria 4
AE - Emirati Arabi Uniti 3
PA - Panama 3
RO - Romania 3
A1 - Anonimo 2
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
NO - Norvegia 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CY - Cipro 1
GD - Grenada 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MQ - Martinica 1
MU - Mauritius 1
NI - Nicaragua 1
PR - Porto Rico 1
SC - Seychelles 1
Totale 8.222
Città #
Ashburn 474
Fairfield 418
Singapore 332
Woodbridge 317
Chandler 295
San Jose 239
Ann Arbor 206
Dallas 201
Hong Kong 178
Houston 176
Milan 173
Seattle 168
Wilmington 157
Beijing 152
Cambridge 152
Nyköping 152
Jacksonville 124
Bari 100
Council Bluffs 92
Los Angeles 77
Rome 59
Lauterbourg 56
New York 53
Roxbury 53
Lawrence 52
Nanjing 51
Ho Chi Minh City 45
Santa Clara 43
Des Moines 40
Helsinki 38
Inglewood 30
São Paulo 28
Princeton 26
San Diego 26
Boardman 25
Abidjan 24
Buffalo 23
Jakarta 22
London 21
Munich 20
Brussels 19
Chicago 18
Columbus 18
Hanoi 17
Warsaw 17
Frankfurt am Main 16
Montreal 16
Brooklyn 15
Dong Ket 15
Baghdad 14
Falkenstein 14
Figino 14
Mexico City 14
Rio de Janeiro 14
Grottaglie 13
Moscow 13
Tokyo 13
Toronto 13
Denver 12
Hebei 12
Johannesburg 12
Nanchang 12
San Francisco 12
Atlanta 11
Chennai 11
Nuremberg 11
Orem 11
Turku 11
York 11
Jiaxing 10
Shenyang 10
Belgrade 9
Belo Horizonte 9
Changsha 9
Da Nang 9
Dhaka 9
Shanghai 9
Brasília 8
Brno 8
Florence 8
Phoenix 8
Quito 8
Stockholm 8
Tianjin 8
Ankara 7
Campinas 7
Mumbai 7
Naples 7
Redwood City 7
Tashkent 7
Amman 6
Amsterdam 6
Bogotá 6
Boston 6
Charlotte 6
Curitiba 6
Dublin 6
Düsseldorf 6
Groningen 6
Madrid 6
Totale 5.549
Nome #
Utilizzo di safe dose di rTPA nel trattamento dell'embolia polmonare massiva associata ad elevato rischio emorragico: Caso clinico e revisione della letteratura 259
A long-term treatment with taurine prevents cardiac dysfunction in mdx mice 250
A novel injectable formulation of 6-Fluoro-L-DOPA imaging agent for diagnosis of neuroendocrine tumors and Parkinson’s disease 234
ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force 231
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 205
In vivo longitudinal study of rodent skeletal muscle atrophy using ultrasonography 204
Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options 204
Antiproliferative effects of neuroprotective drugs targeting big Ca2+-activated K+ (BK) channel in the undifferentiated neuroblastoma cells 202
Carbonic anhydrase inhibitors ameliorate the symptoms of hypokalaemic periodic paralysis in rats by opening the muscular Ca2+-activated-K+ channels 198
Acetazolamide prevents vacuolar myopathy in skeletal muscle of K+-depleted rats 198
Bridging repair of the abdominal wall in a rat experimental model. Comparison between uncoated and polyethylene oxide-coated equine pericardium meshes 174
Reduced expression of Kir6.2/SUR2A subunits explains KATP deficiency in K+-depleted rats 167
Ergogenic effect of bcaas and l-alanine supplementation: Proof-of-concept study in a murine model of physiological exercise 158
The large conductance Ca2+ -activated K+ (BKCa) channel regulates cell proliferation in SH-SY5Y neuroblastoma cells by activating the staurosporine-sensitive protein kinases 155
The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia 155
Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+ - deficient rats 144
Ultrasonography validation for early alteration of diaphragm echodensity and function in the mdx mouse model of Duchenne muscular dystrophy 144
Single-dose extended-toxicity preclinical study on novel radiotracer formulations for use in the diagnosis of neuroendocrine tumor and neurodegenerative disorders 143
Molecular structure and function of big calcium-activated potassium channels in skeletal muscle: Pharmacological perspectives 143
Calcium-Activated K Channel Regulates Cell Viability in Hyperkalemic and Hypokalemic Conditions: Implication in the Neuromuscular Disoders 142
Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery 137
Commentary: A BK (Slo1) channel journey from molecule to physiology. 136
Splicing of the rSlo gene affects the molecular composition and drug response of Ca2+-activated K+ channels in skeletal muscle 135
Pharmaceutical development of novel lactate-based 6-fluoro-L-DOPA formulations 135
Atrophy and phenotype transition signaling exert opposite actions on the KATP channels of disused rat soleus muscle 133
Staurosporine Blocks the ATP-Sensitive K+ Channels and Induces Atrophy in Rodent Skeletal Muscles 133
Molecular determinants for the activating/blocking actions of the 2H-1,4-benzoxazine derivatives, a class of potassium channel modulators targeting the skeletal muscle KATP channels 133
Effects of Acetazolamide on alpha subunit of human BK channel expressed in HEK293 cells 132
Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties 131
Dual response of the KATP channels to staurosporine: a novel role of SUR2B, SUR1 and Kir6.2 subunits in the regulation of the atrophy in different skeletal muscle phenotypes 130
Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle 126
Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type dependent biophysical and pharmacological properties 125
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 124
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 124
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 118
Drugs targeting the metabolically regulated ATP-sensitive potassium channels and big calcium-activated potassium channels in skeletal muscles: Pharmacological perspectives and therapeutic use 118
Effects of Pleiotrophin Overexpression on Mouse Skeletal Muscles in Normal Loading and in Actual and Simulated Microgravity 118
Biophysical and pharmacological characterization of K-ATP and BK channels of slow and fast rat skeletal muscle fibers 111
An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function 109
Effects of the antidiabetic drugs on the age-related atrophy and sarcopenia associated with diabetes type II 107
Calcium activated K+ channel as a target of prompt-to-use drugs in neuromuscular disorders 102
Phenotype-dependent functional and pharmacological properties of BK channels in skeletal muscle: Effects of microgravity 102
Structural nucleotide analogs are potent activators/inhibitors of pancreatic beta-cell KATP channels: an emerging mechanism supporting their use as anti-diabetic drugs. 102
The KATP channel is a molecular sensor of atrophy in skeletal muscle 101
Consequences of SUR2[A478V] Mutation in Skeletal Muscle of Murine Model of Cantu Syndrome 101
An olive oil–derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function 99
Pathophysiological Consequences of KATP Channel Overactivity and Pharmacological Response to Glibenclamide in Skeletal Muscle of a Murine Model of Cantù Syndrome 98
Bendroflumethiazide a potent opener of human BK channel : a new perspective for an old drug in the treatment of periodic paralysis 97
null 90
Brugada Syndrome: More than a Monogenic Channelopathy 88
Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications 85
Pleiotropic Effects of Direct Oral Anticoagulants in Chronic Heart Failure and Atrial Fibrillation: Machine Learning Analysis 83
Phenotypic-dependent biophysical and pharmacological characteristics of BK channels in skeletal muscle and effects of microgravity 81
Phenotypic-dependent biophysical and pharmacological characteristic of BK channels in skeletal muscle and effects of microgravity 79
Expression of sarcolemmal ion channels in slow and fast-twitch muscles of rodents in simulated and actual microgravity 78
Pharmacovigilance-pharmacological investigations on sulfonylureas and glinides-induced atrophy in skeletal muscle 77
null 77
The biophysical properties, pharmacological responses and molecular composition of KATP channels in skeletal muscle type specific 75
The biophysical properties, pharmacological responses and molecular composition of KATP channels in skeletal muscle are muscle type specific 75
null 68
Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach 65
Emerging role of calcium-activated potassium channel in the regulation of cell viability following potassium ions challenge in HEK293 cell and pharmacological modulation 61
Meta-regression analysis on the impact of medical therapy on long-term outcome in spontaneous coronary artery dissection 57
Opening/blocking actions of pyruvate kinase antibodies on neuronal and muscular KATP channels 50
null 49
How brachial access compares to femoral access for invasive cardiac angiography when radial access is not feasible: A meta-analysis 44
CUPID: A free drug discovery platform for the explainable multi-ion channel assessment of cardiotoxicity 36
Biomarker profiles that differentiate type-1 and type 2 myocardial infarction 33
Impact of Frailty on Outcome of Older Patients With Non-ST Elevation Acute Myocardial Infarction Who Undergo Percutaneous Coronary Intervention 26
Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model. 21
Natural history study of the D2-mdx mouse for Duchenne muscular dystrophy: a comparison across two independent study sites 15
Drug repurposing based on integrated in silico and in vitro approach to find a therapy for KCNA2-related disorders 7
Diaphragm‐specific effects of L‐citrulline in mdx mice highlight its potential as adjuvant of standard therapy in Duchenne muscular dystrophy 7
Totale 8.454
Categoria #
all - tutte 33.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.635


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022374 0 0 7 25 19 29 21 21 29 39 67 117
2022/2023780 89 96 58 70 87 94 9 83 132 8 30 24
2023/2024327 20 45 20 34 55 58 4 22 3 23 7 36
2024/20251.271 53 25 76 51 44 120 151 147 64 70 158 312
2025/20262.964 366 143 285 276 347 119 293 78 319 271 106 361
2026/2027322 101 132 89 0 0 0 0 0 0 0 0 0
Totale 8.454